Last updated: May 30, 2026
LEVO-T drug suppliers and manufacturing sources: Who makes levofloxacin tablets by strength and labeler?
Executive summary: No authoritative supplier/manufacturer list can be produced for “LEVO‑T” from the information provided. “LEVO‑T” is a brand name used by multiple markets and strengths for levofloxacin (a fluoroquinolone antibiotic), and supplier identification requires exact country, dosage form (tablet vs suspension), strength (e.g., 250 mg/500 mg), and the specific label/MAH name that maps to the FDA Orange Book, WHO/GS1, national drug registries, or market authorization dossiers.
Because the input does not identify the exact marketed product (country + strength + dosage form + applicant/labeler), generating supplier names or factory sites would require unverifiable assumptions.
Which company supplies the LEVO‑T brand (levofloxacin) in the market you mean?
Featured-snippet answer: Not determinable from the provided label “LEVO‑T” alone.
What active ingredient and dosage strength does LEVO‑T contain?
Featured-snippet answer: LEVO‑T is commonly used for levofloxacin, but multiple strengths and dosage forms exist under similar brand naming across jurisdictions.
Tablet vs suspension vs ophthalmic products
- Levofloxacin is sold as oral tablets, oral solutions, and ophthalmic formulations in different brands and naming conventions.
- Supplier lists vary by dosage form due to different manufacturing lines and regulatory approvals.
What is the Orange Book status of LEVO‑T (levofloxacin) and which manufacturers are listed?
Featured-snippet answer: Not determinable from “LEVO‑T” alone.
Why Orange Book listings depend on the exact FDA product identifier
- Orange Book is keyed to a specific FDA application/labeler and NDC with strength and dosage form.
- A brand-name identifier without the NDC and strength cannot be mapped to the correct Orange Book entry reliably.
How do you identify LEVO‑T suppliers using NDC and labeler data?
Featured-snippet answer: Supplier mapping requires the exact NDC (or the application number) for the specific marketed strength and dosage form.
Typical mapping logic
- Brand label (LEVO‑T) → specific NDC → labeler/manufacturer name(s) → FDA application → patent and exclusivity mapping (if applicable) and manufacturing site identifiers.
- Without that mapping key, any supplier list risks mixing different markets and different levofloxacin products.
What patent estate suppliers are likely tied to LEVO‑T in the US?
Featured-snippet answer: Not determinable without the specific FDA product entry.
Generic levofloxacin supply chain varies by strength
- Patent and data exclusivity status can differ by:
- Immediate-release vs other formulations
- Strength (250 mg vs 500 mg)
- Any formulation-specific manufacturing process claims
Which generic manufacturers compete with LEVO‑T (levofloxacin) by strength?
Featured-snippet answer: Not determinable from “LEVO‑T” alone.
Competition differs by jurisdiction
- In some markets, multiple local generics share the same brand prefix.
- In others, the brand maps to a single authorized MAH with one manufacturing network.
What manufacturing sites supply LEVO‑T (API and finished-dose)?
Featured-snippet answer: Not determinable from the provided input.
API vs finished dose
- Finished-dose labelers often source:
- Levofloxacin API from one or more specialty API manufacturers
- Finished tablets from contract manufacturers or internal plants
- Site-level disclosure typically requires regulatory filings (or NDC-to-site datasets), not brand text.
Key Takeaways
- “LEVO‑T” is not a sufficient identifier to list verified suppliers or manufacturing sources.
- A supplier list must be anchored to the exact product identity (country, dosage form, strength, and the regulatory product identifier such as NDC or MAH labeler).
- Without that mapping key, any supplier names would be speculative and risk cross-wiring different levofloxacin products.
FAQs
-
How can I find the real manufacturer behind the LEVO‑T brand name?
Use the product’s NDC (US) or local registry identifier to map brand → labeler → application → manufacturing details.
-
Does LEVO‑T always mean the same levofloxacin strength and dosage form?
No. Brand prefixes like “LEVO‑T” can be used for multiple strengths and dosage forms across markets.
-
Are the LEVO‑T suppliers the same for 250 mg and 500 mg tablets?
They can be different if the labeler uses multiple strengths with different manufacturing partners or sites.
-
Which dataset lists the suppliers for LEVO‑T in the US?
The FDA Orange Book and NDC labeler/applicant identifiers are the primary structured sources for mapping to product/manufacturer entities.
-
Can supplier identification be done from package text alone?
Sometimes the label prints the manufacturer/MAH name, but package text varies by country and does not always provide the legal entity tied to the regulatory listing.
References
No sources were cited because the provided prompt does not include an identifiable regulatory product record to anchor supplier data.
